SI2846805T1 - Zdravljenje zasvojenosti in motenj v obvladovanju impulzov z uporabo inhibitorjev PDE7 - Google Patents

Zdravljenje zasvojenosti in motenj v obvladovanju impulzov z uporabo inhibitorjev PDE7

Info

Publication number
SI2846805T1
SI2846805T1 SI201331354T SI201331354T SI2846805T1 SI 2846805 T1 SI2846805 T1 SI 2846805T1 SI 201331354 T SI201331354 T SI 201331354T SI 201331354 T SI201331354 T SI 201331354T SI 2846805 T1 SI2846805 T1 SI 2846805T1
Authority
SI
Slovenia
Prior art keywords
addiction
impulse
treatment
control disorders
pde7 inhibitors
Prior art date
Application number
SI201331354T
Other languages
English (en)
Slovenian (sl)
Inventor
Gregory A. Demopulos
George A. Gaitanaris
Roberto Ciccocioppo
Original Assignee
Omeros Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/835,607 external-priority patent/US9220715B2/en
Application filed by Omeros Corporation filed Critical Omeros Corporation
Publication of SI2846805T1 publication Critical patent/SI2846805T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI201331354T 2012-05-07 2013-05-07 Zdravljenje zasvojenosti in motenj v obvladovanju impulzov z uporabo inhibitorjev PDE7 SI2846805T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261643611P 2012-05-07 2012-05-07
US13/835,607 US9220715B2 (en) 2010-11-08 2013-03-15 Treatment of addiction and impulse-control disorders using PDE7 inhibitors
EP13793319.8A EP2846805B1 (en) 2012-05-07 2013-05-07 Treatment of addiction and impulse-control disorders using pde7 inhibitors
PCT/US2013/039866 WO2013176877A2 (en) 2012-05-07 2013-05-07 Treatment of addiction and impulse-control disorders using pde7 inhibitors

Publications (1)

Publication Number Publication Date
SI2846805T1 true SI2846805T1 (sl) 2019-04-30

Family

ID=49624481

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201331354T SI2846805T1 (sl) 2012-05-07 2013-05-07 Zdravljenje zasvojenosti in motenj v obvladovanju impulzov z uporabo inhibitorjev PDE7

Country Status (10)

Country Link
EP (1) EP2846805B1 (enExample)
JP (1) JP2015521177A (enExample)
CN (3) CN104768556A (enExample)
AU (1) AU2013266793B2 (enExample)
CA (1) CA2871151C (enExample)
IN (1) IN2014DN10404A (enExample)
PL (1) PL2846805T3 (enExample)
RS (1) RS58381B1 (enExample)
SI (1) SI2846805T1 (enExample)
WO (1) WO2013176877A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130124333A (ko) 2010-11-08 2013-11-13 오메로스 코포레이션 Pde7 억제제를 사용한 중독 및 충동-조절 장애의 치료
US9220715B2 (en) 2010-11-08 2015-12-29 Omeros Corporation Treatment of addiction and impulse-control disorders using PDE7 inhibitors
EP3505171A4 (en) * 2016-08-26 2020-08-26 Mitsubishi Tanabe Pharma Corporation NITROGEN BICYCLIC HETEROCYCLIC COMPOUND
EP4541372A1 (en) * 2022-06-15 2025-04-23 Shinichi Matsumoto Drug therapy for obsessive-compulsive disorder targeting dopamine d1 signal in striatal striosomes
CN119894518A (zh) 2022-08-18 2025-04-25 米托迪治愈有限责任公司 取代的苯并噁唑和苯并呋喃化合物用于治疗和预防与慢性疲劳、筋疲力尽和/或劳累不耐受相关的疾病的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2437755T3 (es) * 2004-07-01 2014-01-14 Daiichi Sankyo Company, Limited Intermedios para derivados de tienopirazol que tienen actividad inhibitoria de PDE 7
US20060183763A1 (en) * 2004-12-31 2006-08-17 Pfizer Inc Novel pyrrolidyl derivatives of heteroaromatic compounds
PT1928438E (pt) * 2005-09-26 2013-04-03 Avigen Inc Método para tratamento de dependências de drogas e comportamentos
US8637528B2 (en) * 2007-03-27 2014-01-28 Omeros Corporation Use of PDE7 inhibitors for the treatment of movement disorders
NZ580413A (en) * 2007-03-27 2012-11-30 Omeros Corp The use of pde7 inhibitors for the treatment of movement disorders
MX2009010854A (es) * 2007-04-11 2010-01-28 Omeros Corp Composiciones y metodos para profilaxis y tratamiento de adicciones.
FR2943673B1 (fr) * 2009-03-27 2013-03-29 Sanofi Aventis Applications therapeutiques de derives de quinazolinedione
FR2944282B1 (fr) * 2009-04-09 2013-05-03 Sanofi Aventis Derives de quinazolinedione, leur preparation et leurs diverses applications therapeutiques
KR20130124333A (ko) * 2010-11-08 2013-11-13 오메로스 코포레이션 Pde7 억제제를 사용한 중독 및 충동-조절 장애의 치료

Also Published As

Publication number Publication date
RS58381B1 (sr) 2019-04-30
JP2015521177A (ja) 2015-07-27
WO2013176877A3 (en) 2015-06-18
CN114984229A (zh) 2022-09-02
CA2871151A1 (en) 2013-11-28
CN104768556A (zh) 2015-07-08
PL2846805T3 (pl) 2019-05-31
IN2014DN10404A (enExample) 2015-08-14
EP2846805A4 (en) 2016-08-10
CA2871151C (en) 2019-03-26
WO2013176877A2 (en) 2013-11-28
AU2013266793A1 (en) 2014-11-27
EP2846805A2 (en) 2015-03-18
AU2013266793B2 (en) 2016-08-04
CN112168972A (zh) 2021-01-05
EP2846805B1 (en) 2018-11-21

Similar Documents

Publication Publication Date Title
IL261768B (en) Devices and methods for tissue treatment
ZA202108991B (en) Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms
GB2498121B (en) Treatment device and method of use
EP2887805A4 (en) COMPOUNDS AND METHOD FOR TREATING BLOOD HIGH PRESSURE
PL2825161T3 (pl) Inhibitory ludzkiej ezh2 i sposoby ich zastosowania
IL226203A0 (en) Use of pde7 suppressors and preparations containing them for the treatment of sales and disorders
SG11201504022RA (en) Glutamase inhibitors and method of use
EP2542147A4 (en) DEVICES AND METHOD FOR TREATING PSYCHICAL INTERFERENCE
IL241026B (en) A head device for treating and evaluating medical conditions
IL237528B (en) Methods for preventing and treating preeclampsia
EP2870138A4 (en) N-SUBSTITUTED BENZAMIDES AND METHOD OF USE THEREOF
SMT201700451T1 (it) Antagonisti di wnt e metodi di trattamento
EP2701619A4 (en) BONE TASTING INSTRUMENT AND METHODS OF USE
GB201217296D0 (en) Method of treatment and/or prevention
ZA201408055B (en) Compositions and methods for the treatment of local pain
EP2707000A4 (en) TREATMENT AND CONTROL OF CNS DISORDERS
LT2827883T (lt) Tfpi inhibitoriai ir jų panaudojimo būdai
ZA201607980B (en) Use of telomerase inhibitors for the treatment of myeloproliferative disorders and myeloproliferative neoplasms
ZA201501503B (en) Bio-inoculant and use thereof for treatment of effluents
EP2900314A4 (en) DEVICES AND METHODS FOR STIMULATING HAIR GROWTH
SI2846805T1 (sl) Zdravljenje zasvojenosti in motenj v obvladovanju impulzov z uporabo inhibitorjev PDE7
EP2726079A4 (en) METHOD OF ADMINISTRATION AND TREATMENT
IL235272B (en) Alfentanil preparation for the treatment of acute pain
HUE043518T2 (hu) Függõség és impulzuskontroll zavarok kezelése PDE-7-inhibitorok alkalmazásával
EP2640468A4 (en) ADMINISTRATIVE AND TREATMENT PROCEDURES